Search for other papers by M L M Barreto-Chaves in
Google Scholar
PubMed
Search for other papers by N Senger in
Google Scholar
PubMed
Search for other papers by M R Fevereiro in
Google Scholar
PubMed
Search for other papers by A C Parletta in
Google Scholar
PubMed
Search for other papers by A P C Takano in
Google Scholar
PubMed
contribution of the RAS as an important mediator of these effects. Thyroid hormones Triiodothyronine (T3) and thyroxine (T4) are the major TH produced by follicular cells of the thyroid gland, and they are bound to thyroglobulin protein until their
Search for other papers by Maria Stelmachowska-Banaś in
Google Scholar
PubMed
Search for other papers by Izabella Czajka-Oraniec in
Google Scholar
PubMed
; TGAb, thyroglobulin antibodies; TPOAb, thyroid peroxidase antibodies; TRAb, thyroid-stimulating hormone receptor antibodies; TSH, thyroid stimulating hormone. When IH is suspected and/or hypopituitarism is present, the proceeding diagnostic
Search for other papers by Min Li in
Google Scholar
PubMed
Search for other papers by Ying Chen in
Google Scholar
PubMed
Search for other papers by Jingjing Jiang in
Google Scholar
PubMed
Search for other papers by Yan Lu in
Google Scholar
PubMed
Search for other papers by Zhiyi Song in
Google Scholar
PubMed
Search for other papers by Shengjie Zhang in
Google Scholar
PubMed
Search for other papers by Chao Sun in
Google Scholar
PubMed
Search for other papers by Hao Ying in
Google Scholar
PubMed
Search for other papers by Xiaofang Fan in
Google Scholar
PubMed
Search for other papers by Yuping Song in
Google Scholar
PubMed
Search for other papers by Jialin Yang in
Google Scholar
PubMed
Search for other papers by Lin Zhao in
Google Scholar
PubMed
homeostasis model assessment of insulin resistance index; Nrg4, neuregulin 4; TBIL, total bilirubin; TC, total cholesterol; TG, triglyceride; TGAb, thyroglobulin antibody; TPOAb, anti-thyroid peroxidase antibody; TSH, thyroid-stimulating hormone
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Louise Knøsgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Aase Handberg in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
(TBG) and the thyroid-stimulating effect of human chorionic gonadotropin (hCG). What remains less certain is how pregnancy affects the metabolism of thyroid hormones via the iodothyronine deiodinases types 1, 2, and 3 (D1, D2, and D3). D2 and D3 are
Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Thomas Crezee in
Google Scholar
PubMed
Search for other papers by Mirela Petrulea in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
Search for other papers by Doina Piciu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Martin Jaeger in
Google Scholar
PubMed
Search for other papers by Jan W A Smit in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Theo S Plantinga in
Google Scholar
PubMed
Endocrinology Clinic, Cluj County Emergency Hospital, Cluj-Napoca, Romania
Search for other papers by Carmen E Georgescu in
Google Scholar
PubMed
Department of Nuclear Medicine and Endocrine Tumors, Institute of Oncology ‘Prof. Dr. Ion Chiricuta’, Cluj-Napoca, Romania
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
stimulated thyroglobulin (Tg, <1 pmol/L in the Dutch patients and <0.04 ng/mL in the Romanian patients) in the absence of anti-Tg antibodies and no evidence of loco-regional disease or distant metastasis on the whole body iodine scans (WBS) and/or neck
Search for other papers by Nikolina Zdraveska in
Google Scholar
PubMed
Search for other papers by Maja Zdravkovska in
Google Scholar
PubMed
Search for other papers by Violeta Anastasovska in
Google Scholar
PubMed
Search for other papers by Elena Sukarova-Angelovska in
Google Scholar
PubMed
Search for other papers by Mirjana Kocova in
Google Scholar
PubMed
dyshormonogenesis due to defects of thyroid hormone biosynthesis. The etiologic evaluation of CH is possible through several examinations, such as ultrasonography, scintigraphy, thyroglobulin measurement and perchlorate discharge test. There are also cases where the
Search for other papers by Anne H van der Spek in
Google Scholar
PubMed
Search for other papers by Olga V Surovtseva in
Google Scholar
PubMed
Search for other papers by Saskia Aan in
Google Scholar
PubMed
Search for other papers by Anton T J Tool in
Google Scholar
PubMed
Search for other papers by Annemarie van de Geer in
Google Scholar
PubMed
Search for other papers by Korcan Demir in
Google Scholar
PubMed
Search for other papers by Anja L M van Gucht in
Google Scholar
PubMed
Search for other papers by A S Paul van Trotsenburg in
Google Scholar
PubMed
Search for other papers by Timo K van den Berg in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Search for other papers by Anita Boelen in
Google Scholar
PubMed
secretion of pro-inflammatory cytokines by unstimulated macrophages ( 26 , 27 ), a lower induction of the pro-inflammatory cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) during acute inflammation ( 5 ) and impaired macrophage function in
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Marie Reeberg Sass in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Nicolai Jacob Wewer Albrechtsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Endocrinology and Nephrology, Nordsjællands University Hospital, Hillerød, Denmark
Search for other papers by Jens Pedersen in
Google Scholar
PubMed
Search for other papers by Kristine Juul Hare in
Google Scholar
PubMed
Center for Neonatal Screening, Department of Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark
Search for other papers by Nis Borbye-Lorenzen in
Google Scholar
PubMed
Search for other papers by Katalin Kiss in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Steno Diabetes Center Copenhagen, Gentofte, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Search for other papers by Filip Krag Knop in
Google Scholar
PubMed
Search for other papers by Steen Seier Poulsen in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Niklas Rye Jørgensen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Cathrine Ørskov in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Bolette Hartmann in
Google Scholar
PubMed
set for thyroglobulin ( TG ) (cat. no: QT00095053) was used as negative control. Statistical analyses To assess distribution of data, residual plots and histograms were plotted, and Shapiro–Wilk tests for normality (Swik command) and Brown
Search for other papers by Pan Chen in
Google Scholar
PubMed
Search for other papers by Liqin Pan in
Google Scholar
PubMed
Search for other papers by Wensi Huang in
Google Scholar
PubMed
Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Search for other papers by Juqing Wu in
Google Scholar
PubMed
Search for other papers by Jing Wang in
Google Scholar
PubMed
Search for other papers by Yuying Deng in
Google Scholar
PubMed
Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Search for other papers by Yanying Chen in
Google Scholar
PubMed
according to 2015 ATA guidelines ( 7 ). The patients followed a low-iodine diet for 3–4 weeks and thyroid hormone withdrawal at least 3 weeks before 131 I therapy. The oral 131 I dose depended on the postoperative risk stratification and stimulated
Search for other papers by Jeonghoon Ha in
Google Scholar
PubMed
Search for other papers by Jeongmin Lee in
Google Scholar
PubMed
Search for other papers by Kwanhoon Jo in
Google Scholar
PubMed
Search for other papers by Dong-Jun Lim in
Google Scholar
PubMed
Search for other papers by Moo Il Kang in
Google Scholar
PubMed
Search for other papers by Bong Yun Cha in
Google Scholar
PubMed
Search for other papers by Min-Hee Kim in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is defined as a mildly elevated serum thyroid-stimulating hormone (TSH) level with a serum free thyroxine (FT4) level within the normal range ( 1 ). While treatment of SCH is not mandatory in most